MESA Risk Score vs EchoGuide by ASE
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
MESA Risk Score
This application provides a risk scoring tool for cardiovascular disease, incorporating coronary artery calcium scores. It aims to help guide preventive therapies like diet, exercise, and medication based on individual risk factors. The results are intended to inform, not replace, clinical judgment.
- Cardiovascular disease risk scoring
- Incorporates coronary artery calcium scores
- Guides preventive therapy intensity
- Informs clinical decision-making
- Based on MESA study data
Read full descriptionHide full description
The Multi-Ethnic Study of Atherosclerosis (MESA) is a study of the characteristics of subclinical cardiovascular disease (disease detected non-invasively before it has produced clinical signs and symptoms) and the risk factors that predict progression to clinically overt cardiovascular disease or progression of the subclinical disease. MESA researchers study a diverse, population-based sample of 6,814 asymptomatic men and women aged 45-84 from six field centers across the United States. Approximately 38 percent of the recruited participants are white, 28 percent African-American, 22 percent Hispanic, and 12 percent Asian, predominantly of Chinese descent. The first examination took place over two years, from July 2000-July 2002. It was followed by three examination periods that were 17-20 months in length, and a fifth exam April 2010 – January 2012. Participants are contacted every 9 to 12 months throughout the study to assess clinical morbidity and mortality. The final 18 months of the study are dedicated to close out and data analysis and publication. The MESA CHD Risk Score is the first risk scoring tool to incorporate coronary artery calcium scores. The MESA CHD Risk Score can be used to help guide the intensity of preventive therapies such as diet, exercise, aspirin, blood pressure and cholesterol therapies. The results and recommendations provided by this application are intended to inform but do not replace clinical judgement. Therapeutic options should be individualized and determined after discussion between the patient and their care provider. This app was developed under the direction of the MESA Executive Committee by Ted W. James, MD
EchoGuide by ASE
This medical app offers over 50 calculators, algorithms, and charts based on key guidelines for cardiac care professionals. It allows users to favorite interactive tools for quick access to a wide range of echocardiography measurements and assessments.
- Over 50 calculators, algorithms, and charts
- Based on ASE guidelines
- Favorite interactive tools
- Cardiac care reference
- Echocardiography measurements
Read full descriptionHide full description
ASE’s EchoGuide provides access to over 50 calculators, algorithms, and charts. EchoGuide was developed based on key ASE guidelines for use by healthcare professionals providing cardiac care. One special feature in the app is that users have the ability to select their favorite interactive tools for easy access. Topics include: • Left Ventricle • Left Ventricle Mass • Left Ventricular Diastolic Function • Right Ventricle • Left Atrium • Right Atrium Dimensions & Volumes • Aorta • Aortic Regurgitation • Aortic Stenosis • Mitral Regurgitation • Mitral Stenosis • Tricuspid Regurgitation • Tricuspid Stenosis • Pulmonic Regurgitation • Pulmonic Stenosis • Prosthetic Aortic Valve Function • Prosthetic Mitral Valve Function • Prosthetic Tricuspid Valve Function • Prosthetic Pulmonic Valve Function • Prosthetic Valve Regurgitation EchoGuide is intended for educational/informational use only. EchoGuide is not intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease by aiding clinical decision-making. Please send feedback through the App information page and feel free to leave a review and rating in the App Store.
Screenshots
Verdict
The clearest difference is review sentiment: EchoGuide by ASE at 75% against MESA Risk Score's 15%. EchoGuide by ASE also leads on rating (4.7 vs 2.5) and ratings volume (41 vs 11). MESA Risk Score's advantage is iOS requirement (8.0 vs 14.2). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
EchoGuide by ASE holds the better App Store score, 4.7 against 2.5. Both are backed by a comparable volume of ratings — 11 and 41 respectively. Written reviews point the same way: 15% of MESA Risk Score's written reviews are positive against 75% of EchoGuide by ASE's.
| Parameter | MESA Risk Score | EchoGuide by ASE |
|---|---|---|
| Price | Free | Free |
| Rating | 2.5 (11 ratings) | 4.7 (41 ratings) — better |
| Positive reviews | 15.4% of reviews | 75.0% of reviews — better |
| Number of ratings | 11 | 41 — better |
| Update frequency | — | Monthly |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 8.0 — better | 14.2 |
| Further details — not scored | ||
| Size | 14 MB | 96 MB |
| Age rating | 17+ | 12+ |
| Developer | Johns Hopkins Mobile medicine | American Society of Echocardiography |
Customer experience
MESA Risk Score
EchoGuide by ASE
In-app purchases
MESA Risk Score
No in-app purchases
EchoGuide by ASE
No in-app purchases
Questions
Is MESA Risk Score free?
Is EchoGuide by ASE free?
Which has better reviews, MESA Risk Score or EchoGuide by ASE?
Do MESA Risk Score or EchoGuide by ASE have ads?
Other comparisons















